What do we do with our under-enrolled single-center COVID-19 clinical trials?

Lee, Shing M; Esserman, Denise; Cheung, Ken; Dziura, James; Peduzzi, Peter; Sobieszczyk, Magdalena

Lee, Shing M; Esserman, Denise; Cheung, Ken; Dziura, James; Peduzzi, Peter; Sobieszczyk, Magdalena.

Lee SM; Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY, USA.
Esserman D; Department of Biostatistics, Yale School of Public Health, Yale University, New Haven, CT, USA.
Cheung K; Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY, USA.
Dziura J; Department of Biostatistics, Yale School of Public Health, Yale University, New Haven, CT, USA.
Peduzzi P; Department of Biostatistics, Yale School of Public Health, Yale University, New Haven, CT, USA.
Sobieszczyk M; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.

Clin Trials ; 18(6): 741-742, 2021 12.

Article in English | MEDLINE | ID: covidwho-1295380

Subject(s)

COVID-19; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Clin Trials Journal subject: Medicine / Therapeutics Year: 2021 Document Type: Article Affiliation country: 17407745211027246

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google